Aerie Pharmaceuticals (NASDAQ:AERI – Get Rating) and Vir Biotechnology (NASDAQ:VIR – Get Rating) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Volatility and Risk Aerie Pharmaceuticals has a beta of 0.39, […]
Virginia Retirement Systems ET AL acquired a new stake in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 11,500 shares of the company’s stock, valued at approximately $105,000. Several other institutional investors and hedge funds have […]
Shares of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) have been assigned an average rating of “Hold” from the eight brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have given a buy recommendation to the […]
Shares of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) have been assigned an average rating of “Hold” from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to […]
Wall Street brokerages expect Aerie Pharmaceuticals, Inc. (NASDAQ:AERI – Get Rating) to report earnings of ($0.66) per share for the current quarter, according to Zacks. Five analysts have made estimates for Aerie Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.79) and the highest estimate coming in at ($0.59). Aerie Pharmaceuticals reported earnings […]